WASHINGTON, D.C. — In a powerful display of patient-led activism, METAvivor Research and Support recently concluded its annual Stage IV Stampede & Summit and Hill Day. Held on October 5-6, the event transformed the nation’s capital into a hub of advocacy, bringing together hundreds of patients, caregivers, and medical professionals to demand legislative action for those living with metastatic breast cancer (MBC).
This year’s summit marked a significant evolution in the organization’s outreach strategy. For the first time in its history, METAvivor successfully integrated a robust in-person presence with a sophisticated virtual advocacy push. This hybrid model allowed advocates across the United States to engage with their congressional representatives via digital tools, ensuring that the voice of the Stage IV community resonated in every district, regardless of a patient’s ability to travel.
Main Facts: A Unified Front for Stage IV Patients
The Stage IV Stampede is the premier advocacy event for the metastatic breast cancer community. Unlike general breast cancer awareness initiatives, METAvivor focuses exclusively on Stage IV—the stage where cancer has spread beyond the breast to other organs and for which there is currently no cure.
The primary objectives of the October summit were three-fold:
- Legislative Pressure: Urging Congress to pass critical legislation that removes barriers to healthcare and accelerates research.
- Funding Parity: Advocating for increased federal appropriations for the National Institutes of Health (NIH) and the Department of Defense (DoD) Breast Cancer Research Program (BCRP), specifically earmarked for metastatic research.
- Civic Engagement: Launching a massive "Make a Plan to Vote" campaign ahead of the November 3rd elections to ensure the MBC community influences the future of healthcare policy.
By utilizing new online advocacy tools, METAvivor enabled supporters to send thousands of emails to members of Congress, focusing on the immediate need for policy changes that address the unique challenges of MBC patients, such as the financial toxicity of long-term treatment and the life-threatening delays in Social Security and Medicare access.
Chronology: From the Summit to the Halls of Power
The two-day event followed a strategic trajectory designed to move from education to direct political action.
October 5: The Summit and Training
The first day was dedicated to the Stage IV Summit, a series of educational workshops and strategy sessions. Participants were briefed on the current legislative landscape, including the status of the Fiscal Year 2027 budget. Experts in oncology and public policy provided advocates with the data points necessary to make a compelling case to lawmakers.
The afternoon sessions focused on "Advocacy Training," where veteran activists coached newcomers on how to share their personal stories effectively. In the world of lobbying, a personal narrative—often referred to as the "heart of the matter"—is the most potent tool a constituent possesses to move a legislator toward a "yes" vote.
October 6: The Hill Day and Virtual Push
On the second day, the "Stampede" officially moved to Capitol Hill. In-person advocates met with Senate and House offices, while simultaneously, the digital "Groundswell" took place online.
Using METAvivor’s new Action Center, thousands of advocates who could not travel due to health or financial constraints participated in a coordinated "Email Blast." This synchronized effort ensured that as staffers were meeting with physical attendees, their inboxes were being filled with supporting data from constituents back home. This pincer maneuver proved highly effective in keeping MBC issues at the forefront of the legislative agenda during a crowded fall session.
Supporting Data: The Stark Reality of Metastatic Breast Cancer
The advocacy efforts are backed by harrowing statistics that highlight a systemic gap in cancer funding and support.
The Funding Gap
While breast cancer receives significant public attention and funding, the metastatic community has historically been underserved. Statistics indicate that while nearly 30% of all early-stage breast cancer patients will eventually metastasize, only an estimated 2% to 5% of overall breast cancer research funding is dedicated specifically to Stage IV research. METAvivor’s advocacy aims to shift this balance, arguing that research into the spread of cancer is the only way to truly end deaths from the disease.
The Metastatic Breast Cancer Access to Care Act
A central pillar of the Hill Day was the push for the Metastatic Breast Cancer Access to Care Act. Under current law, patients who are disabled by Stage IV cancer must wait five months for Social Security Disability Insurance (SSDI) payments to begin and a staggering 24 months for Medicare coverage to kick in.
For a Stage IV patient, two years is a lifetime. Data presented to Congress highlighted that many patients pass away before their Medicare coverage even begins. METAvivor advocates provided data showing that waiving these waiting periods would not only save lives by providing immediate access to specialized care but would also reduce the overall financial burden on the healthcare system by preventing emergency interventions resulting from delayed treatment.
SEER Act and Data Collection
Advocates also pressed for improvements in the Surveillance, Epidemiology, and End Results (SEER) Program. Currently, the U.S. does not accurately track the number of people living with MBC, as the system primarily tracks "initial diagnosis." If a patient is diagnosed at Stage II and later progresses to Stage IV, they are often not counted in metastatic statistics. Accurate data is essential for securing appropriate federal funding and resources.
Official Responses: Voices from the METAvivor Advocacy Team
The leadership at METAvivor expressed profound gratitude for the outpouring of support during the October events. In a formal statement, the METAvivor Advocacy Team emphasized the critical nature of this moment:
"We are grateful for everyone who took time to help educate Members of Congress about MBC, the challenges patients and caregivers face, and policy changes that would make a real difference in their lives. We look forward to building on this energy with Groundswell, our upcoming virtual hill day, in the Spring of 2027."
The team also underscored the urgency of the current legislative session. As Congress works to finalize the fiscal year 2027 budget before the end of the year, METAvivor remains in constant contact with key committees to ensure that research funding for the Department of Defense (DoD) Breast Cancer Research Program (BCRP) remains a priority.
"There is still work to be done this fall," the team noted. "Look out for our November and December updates on our key legislative issues and research funding as Congress works to finalize the fiscal year 2027 budget before the current Congressional session draws to a close."
Implications: The Intersection of Advocacy and the Ballot Box
The timing of the Stage IV Stampede is no coincidence. With Election Day set for November 3rd, METAvivor is making a direct link between legislative advocacy and the power of the vote.
The Stakes of the November 3rd Election
The implications of the upcoming election for the Stage IV community are monumental. The Senators and Representatives elected this November will be responsible for:
- Determining the final allocations for the FY 2027 and FY 2028 federal budgets.
- Deciding the fate of the Affordable Care Act and protections for pre-existing conditions.
- Setting the agenda for the House Energy and Commerce Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee.
METAvivor has launched a comprehensive "Voting Center" on their new Action Page. By entering a zip code, patients and their families can access early voting details, locate polling places, and, crucially, learn about the candidates’ records on healthcare and medical research funding.
The Long-Term Outlook
The October Stampede was not an isolated event but the beginning of a sustained campaign leading into 2027. The organization is already preparing for its "Groundswell" virtual hill day in the Spring of 2027, which will serve as a follow-up to ensure that the promises made by newly elected officials are kept.
The transition to a hybrid advocacy model suggests a permanent shift in how health-related lobbying will function in the future. By lowering the barrier to entry, METAvivor is empowering a population that is often too ill to participate in traditional protest or lobbying, effectively weaponizing the "digital constituent" to effect real-world change.
As the current Congressional session draws to a close, the Stage IV community stands at a crossroads. The momentum generated in Washington D.C. this October has set the stage for significant policy shifts. However, as the METAvivor Advocacy Team reminds its supporters, the ultimate power lies in the hands of the voters on November 3rd. The fight for Stage IV research is not just fought in the lab or the hospital—it is fought in the halls of Congress and at the ballot box.
For more information on how to participate in year-end advocacy or to find your polling place, visit the METAvivor Action Center at metavivor.org/action-center/.
About the Author
